TCTMD
TMD is a leading online platform dedicated to interventional cardiology, offering extensive insights into the percutaneous management of heart conditions. Since its debut at TCT 2000, TCTMD has been a valuable resource for healthcare providers and industry stakeholders, providing updates on the fast-changing landscape of cardiovascular medicine. Users can access news and information from global conferences, along with the latest advancements in devices and medications that are essential in everyday cardiology practice. TCTMD is managed by the Cardiovascular Research Foundation (CRF), which is committed to enhancing the quality of life for individuals with cardiovascular issues. CRF aims to promote the development and application of safe, effective, and minimally invasive treatments for heart disease. For further details, please visit our website at http://www.crf.org.
Outlet metrics
Global
#259140
United States
#113279
Health/Medicine
#959
Articles
-
4 days ago |
tctmd.com | Caitlin Cox
The observational data can’t capture details like the timing, amount, and type of exposure. Still, there’s a “safety signal.” Cannabis use does in fact raise the risk of major adverse cardiovascular events—acute coronary syndromes, stroke, and CV death—a new meta-analysis confirms, though many specifics related to the type and amount of exposure are still elusive.
-
1 week ago |
tctmd.com | Michael O'Riordan
Release of cardiac troponin after intense endurance exercise is common, but it doesn’t signal occult disease. Elevations in cardiac troponin (cTn) after long bouts of aerobic exercise are not associated with subclinical coronary artery disease in middle-aged athletes, a new study shows.
-
1 week ago |
tctmd.com | L.A. McKeown
The test of nonaerobic functioning may raise awareness that people need to work on balance and flexibility as they age. The ability to lower yourself to the floor and get back up without using your hands may be a risk predictor for natural and cardiovascular mortality, Brazilian researchers say.
-
1 week ago |
tctmd.com | Todd Neale
Underexpansion of the Acurate neo and neo2 transcatheter heart valves (Boston Scientific) is tied to a greater risk for stroke, a Swiss study affirms.
-
1 week ago |
tctmd.com | Caitlin Cox
Most cases are subclinical, but given the newness of the therapy, it’s necessary to keep tabs on the issue going forward. Approximately one in nine patients develop leaflet thrombosis in the first 10 months after transcatheter tricuspid valve replacement (TTVR), according to a meta-analysis. Most cases are subclinical, but researchers say they may yet be tied to future problems, so it’s important to keep tabs on the complication as the treatment’s use expands. Led by Mark J.
TCTMD journalists
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Contact Forms
Contact Form
Website
http://tctmd.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →